Rituximab Administration in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

Children and adolescents with newly diagnosed B-acute lymphoblastic leukemia treated on the St. Jude Total XVII study were randomized to induction therapy with or without rituximab on day 3 or on days 6 and 24.